Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125354782 | 12535478 | 2 | F | 20160125 | 20160808 | 20160707 | 20160810 | EXP | PHHY2016JP092433 | NOVARTIS | 83.00 | YR | M | Y | 0.00000 | 20160810 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125354782 | 12535478 | 1 | PS | STARSIS | NATEGLINIDE | 1 | Oral | 21204 | |||||||||||
| 125354782 | 12535478 | 2 | SS | ONBREZ | INDACATEROL | 1 | Oral | UNK | 0 | DRY POWDER INHALER | |||||||||
| 125354782 | 12535478 | 3 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, QW4 | 160400 | MG | 0 | 400 | MG | ||||||
| 125354782 | 12535478 | 4 | SS | MEPTIN | PROCATEROL HYDROCHLORIDE | 1 | Respiratory (inhalation) | UNK | 0 | ||||||||||
| 125354782 | 12535478 | 5 | SS | TAKEPRON | LANSOPRAZOLE | 1 | Oral | 0 | |||||||||||
| 125354782 | 12535478 | 6 | SS | HARNAL | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.2 MG, UNK | 0 | .2 | MG | ||||||||
| 125354782 | 12535478 | 7 | SS | LIVALO | PITAVASTATIN CALCIUM | 1 | Oral | 0 | |||||||||||
| 125354782 | 12535478 | 8 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 0 | |||||||||||
| 125354782 | 12535478 | 9 | SS | MUCOSOLVAN | AMBROXOL HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
| 125354782 | 12535478 | 10 | SS | MUCODYNE | CARBOCYSTEINE | 1 | Oral | 0 | |||||||||||
| 125354782 | 12535478 | 11 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 2 MG, QD | 0 | 2 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125354782 | 12535478 | 1 | Rheumatoid arthritis |
| 125354782 | 12535478 | 2 | Product used for unknown indication |
| 125354782 | 12535478 | 3 | Rheumatoid arthritis |
| 125354782 | 12535478 | 4 | Product used for unknown indication |
| 125354782 | 12535478 | 5 | Product used for unknown indication |
| 125354782 | 12535478 | 6 | Benign prostatic hyperplasia |
| 125354782 | 12535478 | 7 | Product used for unknown indication |
| 125354782 | 12535478 | 8 | Product used for unknown indication |
| 125354782 | 12535478 | 9 | Product used for unknown indication |
| 125354782 | 12535478 | 10 | Product used for unknown indication |
| 125354782 | 12535478 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125354782 | 12535478 | HO |
| 125354782 | 12535478 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125354782 | 12535478 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125354782 | 12535478 | 3 | 20140219 | 20160121 | 0 |